Department of Clinical Hematology, PGIMER, Chandigarh, India.
Department of Internal Medicine, PGIMER, Chandigarh, India.
BMJ Case Rep. 2021 Feb 8;14(2):e238034. doi: 10.1136/bcr-2020-238034.
Rapidly progressive ascites is a frequent clinical manifestation of advanced abdominal malignancies or portal hypertension due to liver diseases. We report a case of 61-year-old man who presented with rapidly progressive ascites. The presence of ascites, generalised lymphadenopathy, osteosclerosis on imaging and hepatosplenomegaly initially pointed towards the diagnosis of advanced high-grade lymphoma or accelerated myeloid neoplasm. Lymph node biopsy revealed infiltration by CD45, cKIT and CD30; tryptase and toluidine blue-positive mast cells (MCs). Bone marrow examination revealed infiltration by MCs and next generation sequencing revealed the pathognomic exon 17 D 816V KIT mutation. The patient was started on weekly pegylated interferon with significant symptom relief. Systemic mastocytosis should be considered as a differential diagnosis in a clinical case of ascites of unknown aetiology even in the absence of typical skin manifestations.
迅速进展性腹水是晚期腹部恶性肿瘤或肝脏疾病导致的门静脉高压的常见临床表现。我们报告了一例 61 岁男性患者,其表现为迅速进展性腹水。腹水、全身淋巴结病、影像学上的骨硬化和肝脾肿大最初提示为晚期高级别淋巴瘤或加速髓系肿瘤的诊断。淋巴结活检显示 CD45、cKIT 和 CD30 的浸润;类胰蛋白酶和甲苯胺蓝阳性肥大细胞(MCs)。骨髓检查显示 MCs 的浸润,下一代测序显示特征性外显子 17 D816V KIT 突变。患者开始每周接受聚乙二醇干扰素治疗,症状明显缓解。即使没有典型的皮肤表现,在腹水病因不明的临床病例中,也应考虑全身性肥大细胞增多症作为鉴别诊断。